BIG TECH IN HEALTHCARE: Here's who wins and loses as Alphabet, Amazon, Apple, and Microsoft hone in on niche sectors of healthcare
This is a preview of The Big Tech in Healthcare research report from Business Insider Intelligence. Purchase this report. Business Insider Intelligence offers even more technology coverage with Connectivity & Tech Pro. Subscribe today to receive industry-changing connectivity news and analysis to your inbox.
The Big Four tech companies — Alphabet, Amazon, Apple, and Microsoft — are accelerating their pursuit of the healthcare market, and they're starting to hone their strategies in on specific corners of the ecosystem.
US healthcare players are being forced to move on their digital transformation efforts, and Alphabet, Amazon, Apple, and Microsoft are lending their data prowess and tech-savviness to become attractive partners for the job. Healthcare organizations have to contend with a population that's growing sicker, heightened costs, and shifting consumer demands for fast and convenient services. Further, the electronic health record (EHR) boom over the last decade has ushered in the need for organizations to revamp infrastructure and IT strategies. The Big Four have stepped in to alleviate these issues, bridging technological gaps that give health organization partners the opportunity to realize cost savings and bolster their top lines. These players are ramping up their efforts to reshape healthcare by developing and collaborating on new tools that could be a boon to consumers, medical professionals, and insurers. And they're zeroing in on specific areas within healthcare: For instance, Microsoft dropped its consumer-facing wearables and health record system to narrow its focus on its cloud offerings for health systems, Apple is knuckling down on clinical research initiatives via its wearables, Alphabet is focusing on its AI expertise to drive precision medicine, and Amazon is reaching across the board — from pharmacy to medical supply delivery to telehealth. And while their health plays have presented myriad opportunities for healthcare stakeholders, some of the tech giants' initiatives are encroaching on legacy players' businesses and upsetting incumbents. In this report, Business Insider Intelligence explores the key strengths and offerings the Big Four tech giants bring to healthcare — and how each is homing their healthcare strategy in on different corners of the market. We outline how their healthcare plays are causing a tidal change throughout the healthcare industry, examining how each player benefits and threatens healthcare incumbents. Finally, we lay out the barriers holding the Big Four back from reaching their full potential in healthcare. The companies mentioned in this report are: AbbVie, Adidas, Aetna, Allscripts, Alphabet, Amazon, Ancestry, Apple, Ascension, Berkshire Hathaway, Blue Cross Blue Shield, Bright Health, Calico, Cerner, Cleveland Clinic, Clover Health, Color, CVS, CVS Caremark, Deepmind, Devoted Health, Dexcom, Duke University Health, Eli Lilly, Emory Healthcare, Epic, Fitbit, Giant Eagle Pharmacy, Gilead Sciences, Google, GSK, Haven, Health Navigator, iRhythm, JPMorgan Chase, Mayo Clinic, Meditech, Microsoft, Moorfields Eye Hospital, New York-Presbyterian, Nike, Noom, Northwestern Medicine, Novartis, Nuance, Oasis Medical Group, Onduo, Optum, Orbita, Otsuka, Pfizer, PillPack, Premera, Providence St. Joseph Health, Quest Diagnostics, ResMed, Rite Aid, Sanofi, Seattle Children's Hospital, St. Jude Children's Research Hospital, Stanford University, Suki, Summit Pacific Medical Center, Surescripts, UnitedHealthcare, UnitedHealth Group, University of California, University of Chicago, Verily Life Sciences, and Walgreens. Here are some key takeaways from the report:
Alphabet, Amazon, Apple, and Microsoft are gunning to carve out spaces within the healthcare market, and each is targetting its own set of sectors to transform or disrupt. Microsoft is focused on its race with Amazon and Google to lay claim to the healthcare cloud market, Apple is knuckling down on clinical research initiatives via its wearables, Alphabet is focusing on its AI expertise to drive precision medicine, and Amazon is shaping up to disrupt the pharmacy, virtual care, and telehealth realms. Their moves into healthcare are providing health systems with tech needed to patch up interoperability and data sharing gaps, giving healthcare payers a chance to collect a more comprehensive set of health data for members, and granting pharma companies the ability to streamline drug development and manufacturing. But tech giants' forward march into healthcare is, in some cases, troubling incumbents. Amazon's prescription delivery play has traditional pharmacies looking for ways to retain their customer bases, for instance, and Alphabet is building an ecosystem that we think could put it at odds with top dogs in the EHR industry. And their inroads into the healthcare space may be stymied by consumers' meager trust in tech companies handling their health information as well as a rampant cybersecurity crisis that could have healthcare firms holding off on tech investments.
In full, the report:
Provides an overview of Alphabet's, Amazon's, Apple's, and Microsoft's most prominent healthcare projects and plans. Highlights the persistent gaps in the US healthcare system that provide these companies and their cutting-edge technologies with entryways into the industry. Identifies the incumbent healthcare players that will benefit from and be threatened by big tech companies' foray into healthcare. Outlines the barriers that are still in place that are stifling tech giants' dive into the health space.
Want to learn more about the fast-moving world of digital health? Here's how to get access:
Purchase & download the full report from our research store. >> Purchase & Download Now Sign up for Digital Health Pro, Business Insider Intelligence's expert product suite keeping you up-to-date on the people, technologies, trends, and companies shaping the future of healthcare, delivered to your inbox 6x a week. >> Get Started Check to see if you already have access to Business Insider Intelligence through your company, or inquire about access if you don't. >> Check If You Have Enterprise Access Current subscribers can read the report here. Join the conversation about this story »
More like this (3)
4 tech giants President Trump calls 'MAGA' stocks have lost $1 trillion in the coronavirus-induced market rout
Four technology giants — Microsoft, Apple, Google-parent Alphabet, and Amazon — have shed more than $1...Four technology giants — Microsoft, Apple, Google-parent Alphabet, and Amazon — have shed more than $1 trillion in market value since all-time highs in February as markets have been roiled by coronavirus, CNBC reported. The four stocks are called "MAGA" stocks by President Trump, and each has boasted a market value of $1 trillion or more at some point. Now, only Microsoft and Apple are valued at more than $1 trillion. Read more on Business Insider. President Donald Trump's favorite technology stocks — which include Microsoft, Apple, Google-parent Alphabet, and Amazon — have lost a combined $1.3 trillion since February as markets reel from the coronavirus outbreak. The tech giants are Trump's favorites because the beginning letters can be arranged to spell "MAGA" — the acronym used by the president during his 2016 campaign. The four tech stocks have also all reached a market value of $1 trillion at some point, which Trump pointed out to a group of reporters in February. The four tech mainstays led US stocks to new highs in February. But since, the companies have slumped amid a broader market sell-off induced by coronavirus panic and an oil price war that's landed all three major US indexes in bear market territory. Microsoft has been the hardest hit in the sell-off, falling nearly 27% from an all-time high close on February 10 and losing roughly $405 billion from its market value. Apple has lost more than 25% and about $372 billion since its closing high on February 12. Amazon and Alphabet both closed at all-time highs on February 19. Since, Alphabet has shed nearly 30% and about $311 billion. Amazon has outperformed the rest of the MAGA group, falling nearly 21% and losing around $239 billion in market value. The moves were first reported by CNBC's Pippa Stevens. Read more: An investment chief whose ETF has surged 24% during the coronavirus meltdown details his strategy for profiting during stock-market crashes Now, only Microsoft and Apple still boast market values of $1 trillion or more. Even though the losses for the four tech giants have been steep, the MAGA stocks have outperformed the broader S&P 500 over the last week and month, according to CNBC. There could be more pain ahead, however, as the coronavirus pandemic slows economic activity around the world, forces store closings, and disrupts global supply chains. Apple on Saturday said that it would shutter all of its stores outside of China until at least March 27 to slow the spread of the virus. The announcement from the company came after it said in February that it would likely miss its quarterly revenue forecast due to the coronavirus outbreak. Join the conversation about this story » NOW WATCH: What if humans tried landing on the sun
Digital Therapeutics Explained: DTx market trends & top companies delivering on the latest digital health opportunity
This is a preview of The Digital Therapeutics research report from Business Insider Intelligence. Purchase this report....This is a preview of The Digital Therapeutics research report from Business Insider Intelligence. Purchase this report. Business Insider Intelligence offers even more healthcare coverage with Digital Health Pro. Subscribe today to receive industry-changing digital health news and analysis to your inbox. A new class of medicine — digital therapeutics (DTx) — has emerged, offering a novel means of treating the swelling number of patients with chronic diseases and keeping associated costs down. Digital therapeutics deliver evidence-based therapies via software — often in the form of consumer-facing mobile health apps — that replace or complement the existing treatment of a disease. They diverge from the broader digital health market in that they must be approved by regulatory bodies — and displaying proof-of-concept is at the core of their model. DTx vendors leverage their tech to treat chronic conditions, which gobble up the lion's share of the US' healthcare spending: Business Insider Intelligence estimates that the US shelled out up to $3.3 trillion on chronic disease in 2018. The surging prevalence of chronic conditions combined with their sky-high price tags is fueling fast growth in the global DTx market, which is poised to expand 21% annually to hit nearly $9 billion by 2025. The sea change sparked by the advent of digital medicines threatens to reshape the entire healthcare value chain. Because drugs interact with nearly every healthcare stakeholder, DTx solutions are leading a variety of players to carve out room for digital solutions: Pharmacy benefit managers (PBMs) are creating logs for DTx as they would drugs, insurers are linking their members up with digital solutions in an effort to mitigate spending, and entrenched pharma and medtech companies are tying up with DTx vendors to dip into new revenue streams. Those that choose not to get on the DTx bandwagon might miss out on a massive opportunity — and we think laggard drugmakers and medical device makers that don't jump at the chance of linking up with DTx providers could put themselves at risk of losing market share to new competitors. In this report, Business Insider Intelligence will explore the drivers lighting a fire under the DTx market, identify the leading DTx market players, and unpack the varied ways vendors reach their intended audiences. We will also assess both the opportunities and risks DTx companies and their products pose to payers, pharmaceutical companies, and medtech firms. Finally, we will forecast what we expect to see next in the DTX space and outline the barriers holding DTx firms back to help stakeholders navigate the crowding field and develop strategies to capture a piece of the DTx pie. The companies mentioned in this report are: 23andMe, 2morrow, Inc., Advocate Health Care, Akili Interactive, Apple, Aptar Pharma, Aurora Health Care, Bayer, Better Therapeutics, Big Health, Biofourmis, Blue Shield of California, Cambia Health Solutions, Cigna, Click Therapeutics, Cognoa, CVS Caremark, DarioHealth, Dexcom, Diabeto, Eli Lilly, ExpressScripts, Glooko, Happify Health, Health2Sync, Kaia Health, Lark Health, Livongo, MedRhythms, myStrength, mySugr, Noom, Novartis, Novo Nordisk, Omada Health, Omron, One Drop, Otsuka, Pear Therapeutics, Propeller Health, Proteus Digital Health, ResMed, Retrofit, Roche, Sanofi, Teva Pharmaceutical, Teladoc, UnitedHealth Group, Vida Health, Virta Health, Voluntis, Walgreens, Walmart, and Welldoc. Here are some key takeaways from the report: Digital therapeutics are shaking up the healthcare value chain: The digital therapeutics market is set to triple in size over the next six years, blossoming into a $9 billion opportunity — and Business Insider Intelligence predicts consumer adoption of the digital treatments will grow more than 10-fold by 2023. Payers should stock portfolios with digital therapeutics to shore up on drug spending, curb their sizable share of chronic disease costs, keep patients healthy, and woo employer contracts. Proactive pharmaceutical firms and medical device makers can benefit from DTx's proliferation through tie-ups with vendors that give the incumbents access to piles of real-time data as well as the possibility to expand revenue opportunities through commercializing new products and programs — but sluggish drug- and device makers risk waving goodbye to consumers opting for digital solutions. We expect to see heightened activity in the space over the next several years, but hurdles to growth remain, including winning over doctors and consumers as well as paltry reimbursement from the Centers for Medicare and Medicaid Services. In full, the report: Provides a roadmap to the digital therapeutics market and explains how companies developing digital drug alternatives are transforming healthcare. Identifies key players operating in the space. Explores how digital therapeutics stand to benefit — and threaten — entrenched players, like payers, pharmaceutical companies, and medical device makers. Considers what the future of digital therapeutics looks like and what still stands in the way of their proliferation. Want to learn more about the fast-moving world of digital health? Here's how to get access: Purchase and download the full report from our research store. >> Purchase & Download Now Sign up for Digital Health Pro, Business Insider Intelligence's expert product suite keeping you up-to-date on the people, technologies, trends, and companies shaping the future of healthcare, delivered to your inbox 6x a week. >> Get Started Join thousands of top companies worldwide who trust Business Insider Intelligence for their competitive research needs. >> Inquire About Our Enterprise Memberships Current subscribers can read the report here. Join the conversation about this story »
BIG TECH IN TRANSPORTATION: Strategies legacy players can deploy to limit the threat to their market position
This is a preview of The Big Tech in Transportation research report from Business Insider Intelligence. Purchase...This is a preview of The Big Tech in Transportation research report from Business Insider Intelligence. Purchase this report. To check to see if you already have access to Business Insider Intelligence through your company, click here. Big tech companies — specifically Google-parent Alphabet, Apple, and Amazon — have their eyes set on the transportation space, which is undergoing a rapid transformation. Across the globe, legacy transportation firms are contending with forces that are reducing the appeal of traditional gas-powered vehicles, including the rise of mobility companies like Uber and Lime, regulatory pushes for cleaner vehicles, and consumer demands for a more streamlined, digital in-car experience. These forces have made traditional transportation companies both more vulnerable to challengers and more willing to work with nontraditional players. Having already shown an ability to disrupt traditional industries by rapidly innovating, creating best-in-class user experiences, and earning the loyalty of consumers across the globe, big tech now appears poised to propel the transportation industry into a new era. This includes launching mobility services of their own, backing some of the world's most successful transportation startups, supporting alternative energy sources for vehicles, and bringing their popular tech products into vehicles. In the Big Tech in Transportation report, Business Insider Intelligence examines the moves that Alphabet, Apple, and Amazon are making to gain a larger foothold in the transportation industry. We outline potential next steps each may take based on those moves. Finally, we highlight the different strategies legacy auto firms will use to better compete as big tech companies raise their profiles in transportation. The companies mentioned in this report are: Alphabet, Amazon, Apple, Aurora, Automobile, Ford, GM, Google, Fiat Chrysler, Rivian, Volkswagen, Waymo. Here are some of the key takeaways from the report: Within big tech, Google-parent Alphabet, Apple, and Amazon have been the most active firms to push into the transportation space. Alphabet has quickly ramped up its transportation efforts, becoming the most formidable big tech firm in the space. The company has focused its efforts in three core areas: autonomous driving technology, vehicle operating systems (OSs), and alternative mobility. Despite Apple being quite secretive in its efforts, we know that the iPhone maker is working on self-driving technology and is using its OS to enter the auto space. Amazon, renowned for disrupting countless industries, is deploying an early strategy that appears to be focused on capturing control of the in-car experience with its voice assistant and leveraging new transportation technologies to improve operations. In full, the report: Details the different avenues big tech firms are taking to build out a presence in the lucrative transportation space. Highlights how big tech will look to build out their transportation offerings going forward. Discusses the different strategies automakers can take to ensure they hold onto their respective market positions as big tech becomes a potential competitor. Interested in getting the full report? Here's how to get access: Purchase & download the full report from our research store. >> Purchase & Download Now Join thousands of top companies worldwide who trust Business Insider Intelligence for their competitive research needs. >> Inquire About Our Enterprise Memberships Current subscribers can read the report here. Join the conversation about this story »